Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfacalcidol for Muscle Function in Osteoporosis Patients
NCT06272227Phase 4Not yet recruiting
- Sponsor
- Yonsei University
- Start
- Feb 2024
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of alfacalcidol in Sarcopenia, sponsored by Yonsei University. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
alfacalcidol
03
Conditions
Sarcopenia
Beyond the preview
Go deeper on NCT06272227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06272227.